In an in vivo study, knockdown of SNHG12 resulted in smaller tumor volumes and reduced tumor weights in CaSki cervical cancer cell-derived human xenografts in nude mice compared to the control mice (34). The gene discussed is SNHG12; the disease is cervical cancer.